POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet are: PL08553/0303, PL08553/0299, PL08553/0304, PL08553/0301, PL08553/0300, PL08553/0302.
Olanzapine 2.5, 5, 7.5, 10, 15 and 20 mg film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER
Olanzapine 2.5, 5, 7.5, 10, 15 and 20 mg film-coated Tablets
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you
What is in this leaflet
1. What Olanzapine is and what it is used for
2. What you need to know before you take Olanzapine
3. How to take Olanzapine
4. Possible side effects
5. How to store Olanzapine
6. Contents of the pack and other information
1. WHAT OLANZAPINE IS AND WHAT IT IS USED FOR
Olanzapine contains the active substance olanzapine. Olanzapine belongs to a group of medicines called antipsychotics and is used to treat the following conditions:
Olanzapine has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE OLANZAPINE
Do not take Olanzapine
Warnings and precautions
Talk to your doctor or pharmacist before you take Olanzapine Tablets.
The use of Olanzapine in elderly patients with dementia is not recommended as it may have serious side effects
If you suffer from any of the following illnesses tell your doctor as soon as possible:
If you suffer from dementia, you or your carer/relative should tell your doctor if you have ever had a stroke or "mini" stroke.
As a routine precaution, if you are over 65 years your blood pressure may be monitored by your doctor.
Children and adolescents
Olanzapine is not for patients who are under 18 years.
Other medicines and Olanzapine
Only take other medicines while you are taking Olanzapine Tablets if your doctor tells you that you can. You might feel drowsy if Olanzapine is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).
Tell your doctor if you are taking, have recently taken or might take any other medicines. In particular, tell your doctor if you are taking:
Olanzapine with alcohol
Do not drink any alcohol if you have been given Olanzapine Tablets as together with alcohol it may make you feel drowsy.
Pregnancy and breast-feeding
If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. You should not be given this medicine when breast-feeding, as small amounts of Olanzapine can pass into breast milk.
The following symptoms may occur in newborn babies, of mothers that have used Olanzapine Tablets in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. If your baby develops any of these symptoms you may need to contact your doctor.
Driving and using machines
There is a risk of feeling drowsy when you are given Olanzapine Tablets. If this happens do not drive or operate any tools or machines. Tell your doctor.
Olanzapine Tablets contains lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
3 . HOW TO TAKE OLANZAPINE
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Your doctor will tell you how many Olanzapine
Tablets to take, and how long you should continue to take them. The daily dose of Olanzapine is between 5 mg and 20 mg.
Consult your doctor if your symptoms return but do not stop taking Olanzapine Tablets unless your doctor tells you to.
You should take your Olanzapine Tablets once a day following the advice of your doctor.
Try to take your tablets at the same time each day. It does not matter whether you take them with or without food. Olanzapine Tablets are for oral use. You should swallow the tablets whole with water.
If you take more Olanzapine than you should
Patients who have taken more Olanzapine Tablets than they should, have experienced the following symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness.
Other symptoms may be: acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness, slowing of the breathing rate, aspiration, high blood pressure or low blood pressure, abnormal rhythms of the heart.
Contact your doctor or hospital straight away if you experience any of the above symptoms.
Show the doctor your pack of tablets.
If you forget to take Olanzapine
Take your tablets as soon as you remember.
Do not take two doses in one day.
If you stop taking Olanzapine
Do not stop taking your tablets just because you feel better. It is important that you carry on taking Olanzapine for as long as your doctor tells you.
If you suddenly stop taking Olanzapine, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur. Your doctor may suggest you to reduce the dose gradually before stopping treatment.
If you have any further questions on the use of this medicine ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them. Tell your doctor immediately if you have:
Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness; and increases in levels of prolactin in the blood. In the early stages of treatment, some people may feel dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting position. This will usually pass on its own but if it does not, tell your doctor.
Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Uncommon side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g. swelling in the mouth and throat, itching, rash); diabetes or the worsening of diabetes, occasionally associated with ketoacidosis (ketones in the blood and urine) or coma; seizures, usually associated with a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; problems with speech; slow heart rate; sensitivity to sunlight; bleeding from the nose; abdominal distension; drooling; memory loss or forgetfulness; urinary incontinence; lack of ability to urinate; hair loss; absence or decrease in menstrual periods; and changes in breasts in males and females such as an abnormal production of breast milk or abnormal growth.
Rare side effects (may affect up to 1 in 1000 people) include lowering of normal body temperature; abnormal rhythms of the heart; sudden unexplained death; inflammation of the pancreas causing severe stomach pain, fever and sickness; liver disease appearing as yellowing of the skin and white parts of the eyes; muscle disease presenting as unexplained aches and pains; and prolonged and/or painful erection.
Very rare side effects include serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia).
While taking olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature, redness of the skin and have trouble walking. Some fatal cases have been reported in this particular group of patients.
In patients with Parkinson's disease Olanzapine may worsen the symptoms.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE OLANZAPINE
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiry date, which is stated on the carton. Do not store above 25 °C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Olanzapine Tablets contain:
The active substance is olanzapine. Each film-coated tablet contains 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg or 20 mg of the active substance. The exact amount is shown on your Olanzapine tablet pack.
The other ingredients are lactose monohydrate, microcrystalline cellulose, crospovidone, hydroxypropyl cellulose, magnesium stearate. The tablet coating contains hypromellose, titanium dioxide ( E171), macrogol 400.
What Olanzapine Tablets look like and contents of the pack
Olanzapine 2.5 mg film-coated tablets are white, oval, biconvex film-coated tablets, debossed “OLZ” on one side and “2.5” on other side.
Olanzapine 5 mg film-coated tablets are white to off-white, oval, biconvex film-coated tablets, debossed “OLZ” on one side and “5” on other side.
Olanzapine 7.5 mg film-coated tablets are white to off-white, oval, biconvex film-coated tablets, debossed “OLZ” on one side and “7.5” on other side.
Olanzapine 10 mg film-coated tablets are white to off-white, oval, biconvex film-coated tablets, debossed “OLZ” on one side and “10” on other side.
Olanzapine 15 mg film-coated tablets are white, round, biconvex film-coated tablets, debossed “OLZ” on one side and “15” on other side.
Olanzapine 20 mg film-coated tablets are white, oval, biconvex film-coated tablets, debossed “OLZ” on one side and “20” on other side.
Olanzapine is available in packs containing 7, 14, 28, 35, 56, 70, 98 film-coated tablets. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
This leaflet was last revised in 04/2020
6 Riverview Road, Beverley, Hull, HU17 0LD
+44 (0)1482 860228
+44 (0)1748 828873
+44 (0)1482 389858